JP2022502429A5 - - Google Patents
Info
- Publication number
- JP2022502429A5 JP2022502429A5 JP2021517252A JP2021517252A JP2022502429A5 JP 2022502429 A5 JP2022502429 A5 JP 2022502429A5 JP 2021517252 A JP2021517252 A JP 2021517252A JP 2021517252 A JP2021517252 A JP 2021517252A JP 2022502429 A5 JP2022502429 A5 JP 2022502429A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- ketamine
- dose
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18461615.9 | 2018-09-28 | ||
| EP18461615.9A EP3628313B1 (en) | 2018-09-28 | 2018-09-28 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
| PCT/EP2019/075735 WO2020064748A1 (en) | 2018-09-28 | 2019-09-24 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502429A JP2022502429A (ja) | 2022-01-11 |
| JP2022502429A5 true JP2022502429A5 (https=) | 2022-09-28 |
| JP7444864B2 JP7444864B2 (ja) | 2024-03-06 |
Family
ID=63713806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517252A Active JP7444864B2 (ja) | 2018-09-28 | 2019-09-24 | 肺投与によるうつ病の処置方法における使用のためのケタミン組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11925607B2 (https=) |
| EP (3) | EP3628313B1 (https=) |
| JP (1) | JP7444864B2 (https=) |
| KR (1) | KR102867739B1 (https=) |
| CN (1) | CN113038941A (https=) |
| AU (1) | AU2019349624B2 (https=) |
| BR (1) | BR112021005687A2 (https=) |
| CA (1) | CA3114325A1 (https=) |
| EA (1) | EA202190724A1 (https=) |
| ES (2) | ES3021221T3 (https=) |
| HU (2) | HUE071303T2 (https=) |
| MX (1) | MX2021003668A (https=) |
| PL (2) | PL3628313T3 (https=) |
| WO (1) | WO2020064748A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2907692T3 (es) | 2017-12-29 | 2022-04-26 | Celon Pharma Sa | Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| GB0523031D0 (en) * | 2005-11-11 | 2005-12-21 | Yaupon Therapeutics | Enhancement of morphine analgesia by s(-)-norketamine |
| AU2007229866A1 (en) * | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| DE102007009888A1 (de) | 2007-02-28 | 2008-09-04 | Hermann, Holger Lars, Dr. | Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| WO2013138322A1 (en) * | 2012-03-12 | 2013-09-19 | Janssen Pharmaceutica Nv | Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
| US20140079740A1 (en) | 2012-08-02 | 2014-03-20 | ClinPharm Support GmbH | Oral transmucosal adminstration forms of s-ketamine |
| DK2968221T3 (da) | 2013-03-15 | 2019-08-05 | Janssen Pharmaceutica Nv | Farmaceutisk sammensætning af s-ketaminhydrochlorid |
| US20140274981A1 (en) | 2013-03-15 | 2014-09-18 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
| KR20170040800A (ko) * | 2014-08-13 | 2017-04-13 | 얀센 파마슈티카 엔.브이. | 우울증 치료 방법 |
| US20160338977A1 (en) | 2015-05-20 | 2016-11-24 | Janssen Pharmaceutica Nv | Methods and kits for treating depression |
| CN106562952B (zh) * | 2015-10-09 | 2020-06-09 | 江阴安博生物医药有限公司 | 氯胺酮在治疗重性抑郁障碍中的应用 |
| ES2907692T3 (es) | 2017-12-29 | 2022-04-26 | Celon Pharma Sa | Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento |
-
2018
- 2018-09-28 EP EP18461615.9A patent/EP3628313B1/en active Active
- 2018-09-28 HU HUE18461615A patent/HUE071303T2/hu unknown
- 2018-09-28 PL PL18461615.9T patent/PL3628313T3/pl unknown
- 2018-09-28 ES ES18461615T patent/ES3021221T3/es active Active
-
2019
- 2019-09-24 KR KR1020217011554A patent/KR102867739B1/ko active Active
- 2019-09-24 BR BR112021005687-4A patent/BR112021005687A2/pt unknown
- 2019-09-24 HU HUE19770131A patent/HUE071649T2/hu unknown
- 2019-09-24 ES ES19770131T patent/ES3028459T3/es active Active
- 2019-09-24 JP JP2021517252A patent/JP7444864B2/ja active Active
- 2019-09-24 AU AU2019349624A patent/AU2019349624B2/en active Active
- 2019-09-24 MX MX2021003668A patent/MX2021003668A/es unknown
- 2019-09-24 WO PCT/EP2019/075735 patent/WO2020064748A1/en not_active Ceased
- 2019-09-24 EP EP25162744.4A patent/EP4578505A3/en active Pending
- 2019-09-24 CN CN201980075601.XA patent/CN113038941A/zh active Pending
- 2019-09-24 CA CA3114325A patent/CA3114325A1/en active Pending
- 2019-09-24 PL PL19770131.1T patent/PL3856159T3/pl unknown
- 2019-09-24 EP EP19770131.1A patent/EP3856159B1/en active Active
- 2019-09-24 EA EA202190724A patent/EA202190724A1/ru unknown
- 2019-09-24 US US17/281,136 patent/US11925607B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2025204271A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| ES2979060T3 (es) | Combinaciones de un antagonista de receptores muscarínicos y un agonista de receptores adrenérgicos beta-2 | |
| JP2023036678A5 (https=) | ||
| JP2021510682A5 (https=) | ||
| JP2018528966A5 (https=) | ||
| ES2613754T3 (es) | Uso de glicopirrolato para tratar la taquicardia | |
| RU2016143365A (ru) | Рапамицин-содержащая композиция, вводимая путем ингаляции для лечения возрастных заболеваний | |
| EA201591869A1 (ru) | Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой | |
| NZ606548A (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| RU2006112589A (ru) | Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции | |
| JP2022530637A5 (https=) | ||
| HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
| JP2011513451A5 (https=) | ||
| RU2016117764A (ru) | Рапамицин для лечения лимфангиолейомиоматоза | |
| CA2838030A1 (en) | Combination comprising umeclidinium and a corticosteroid | |
| FI3412277T3 (fi) | Kortikosteroidia ja beeta-adrenergista ainetta käsittävä kuivajauheformulaatio annettavaksi inhalaatiolla | |
| WO2012107765A3 (en) | Particle formulation | |
| JP2013507429A5 (https=) | ||
| WO2013104892A1 (en) | Application of high dose compounds via inhalation | |
| HRP20120286T1 (hr) | Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti | |
| JP2022502429A5 (https=) | ||
| CA2838031A1 (en) | Dry powder inhaler compositions comprising umeclidinium | |
| JP2023523557A5 (https=) | ||
| JP5501451B2 (ja) | 咳の治療のためのテオブロミン | |
| JP2015120758A5 (https=) |